The SARS-CoV-2 variant B.1.617.2 that was first detected in India is likely to become a global problem.
There are two key issues with B.1.617.2:
Vaccination doesn’t completely halt the COVID-19 disease progression
It can lead to symptomatic infection in children
This means that full inoculation of a population with Pfizer or Moderna mRNA vaccines will not …